Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis (Q65543908)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis |
clinical trial |
Statements
PRIVIG (English)
0 references
Randomized, Double-Blind, Placebo-Controlled Study to Compare the Effects of Different Dose Regimens of IGIV Chromatography (IGIV-C), 10% Treatment on Relapses in Patients With Relapsing Remitting Multiple Sclerosis (English)
0 references
December 2002
0 references
February 2005
0 references
128
0 references
18 year
0 references
55 year
0 references